Antineoplastic Combined Chemotherapy Protocols Concept

subject area of

• 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer  Academic Article
• 5-Fluorouracil with Folinic Acid is Not Effective Against Metastatic Adenocarcinoma of the Lung  Academic Article
• HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• A Canadian cancer trials group phase IB study of durvalumab (anti-PD-L1) plus tremelimumab (anti-CTLA-4) given concurrently or sequentially in patients with advanced, incurable solid malignancies  Academic Article
• A Comparison of Elderly Patients with Aggressive Histology Lymphoma who Were Entered or Not Entered on to a Randomized Phase II Trial  Academic Article
• A National Cancer Institute of Canada Clinical Trials Group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer  Academic Article
• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Academic Article
• A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer  Academic Article
• A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer  Academic Article
• A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer  Academic Article
• A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer  Academic Article
• A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer  Academic Article
• A Phase I Trial of Standard and Cyclophosphamide Dose-Escalated CHOP with Granulocyte Colony Stimulating Factor in Elderly Patients with Non-Hodgkin's Lymphoma  Academic Article
• A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma  Academic Article
• A Phase I/II Study of GTI-2040 Plus Docetaxel as Second-Line Treatment in Advanced Non-small Cell Lung Cancer: A Study of the PMH Phase II Consortium  Academic Article
• A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205  Academic Article
• A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium  Academic Article
• A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia  Academic Article
• A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study  Academic Article
• A Prospective, non-randomised phase 1–2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma  Academic Article
• A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial  Academic Article
• A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes  Academic Article
• A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Academic Article
• A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials  Academic Article
• A meta-analysis of Kang`ai injection combined with chemotherapy in the treatment of advanced non-small cell lung cancer  Academic Article
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer  Academic Article
• A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia  Academic Article
• A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer  Academic Article
• A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer  Academic Article
• A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma  Academic Article
• A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia  Academic Article
• A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers  Academic Article
• A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies  Academic Article
• A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)  Academic Article
• A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)  Academic Article
• A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over  Academic Article
• A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041)  Academic Article
• A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer  Academic Article
• A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia  Academic Article
• A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors  Academic Article
• A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186  Academic Article
• A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226  Academic Article
• A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172)  Academic Article
• A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.  Academic Article
• A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer  Academic Article
• A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer  Academic Article
• A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer  Academic Article
• A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group  Academic Article
• A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors  Academic Article
• A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798)  Academic Article
• A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia  Academic Article
• A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer  Academic Article
• A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients  Academic Article
• A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial  Academic Article
• A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7  Academic Article
• A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy  Academic Article
• A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial  Academic Article
• A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer  Academic Article
• A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients  Academic Article
• A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.  Academic Article
• A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients  Academic Article
• A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients  Academic Article
• A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch  Academic Article
• A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer  Academic Article
• A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients  Academic Article
• A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma  Academic Article
• A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy  Academic Article
• ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step  Academic Article
• ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma  Academic Article
• AML refractory to primary induction with Ida-FLAG has a poor clinical outcome  Academic Article
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy  Academic Article
• Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane  Academic Article
• Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma  Academic Article
• Activity of fulvestrant in HER2-overexpressing advanced breast cancer  Academic Article
• Acute Perforative Appendicitis During Preoperative Chemotherapy for Wilms Tumor  Academic Article
• Acute lymphoid leukemia. No evidence of consistent chemotherapy-induced intestinal malabsorption.  Academic Article
• Acute myelogenous leukemia in adolescents and young adults  Academic Article
• Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II study  Academic Article
• Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins  Academic Article
• Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients  Academic Article
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation  Academic Article
• Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis  Academic Article
• Adjuvant Chemotherapy for Breast Cancer — 30 Years Later  Academic Article
• Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review  Academic Article
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial  Academic Article
• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update  Academic Article
• Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing  Academic Article
• Adjuvant Therapy for Premenopausal Women With Breast Cancer: Is It Time for Another Paradigm Shift?  Academic Article
• Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group  Academic Article
• Adjuvant Therapy for completely resected Stage II Colon Cancer  Academic Article
• Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?  Academic Article
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Academic Article
• Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data  Academic Article
• Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials  Academic Article
• Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.  Academic Article
• Adjuvant endocrine therapy of breast cancer  Academic Article
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial  Academic Article
• Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future  Academic Article
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma  Academic Article
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Academic Article
• Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study  Academic Article
• Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia  Academic Article
• An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia  Academic Article
• An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma  Academic Article
• An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001  Academic Article
• Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience  Academic Article
• Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.  Academic Article
• Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.  Academic Article
• Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data  Conference Paper
• Anthracyclines in Early Breast Cancer  Academic Article
• Antiangiogenic Therapies in Non-Small-Cell Lung Cancer  Academic Article
• Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group  Academic Article
• Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)  Academic Article
• Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study  Academic Article
• Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non–small-Cell Lung Cancer  Academic Article
• Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial  Academic Article
• Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients  Academic Article
• Autologous Stem Cell Transplantation in Follicular Lymphoma: a Systematic Review and Meta-analysis  Academic Article
• Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma  Academic Article
• Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas  Academic Article
• Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis  Conference Paper
• Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia  Academic Article
• Azacitidine and its role in the upfront treatment of acute myeloid leukemia  Academic Article
• Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma  Academic Article
• Better Treatments That Cost More: The Dilemma  Academic Article
• Biliary Rhabdomyosarcoma in an Infant Male With Neurofibromatosis Type 1  Academic Article
• Bleomycin-Induced Lung Toxicity and Pentoxifylline  Academic Article
• Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial  Academic Article
• Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium  Academic Article
• Canadian Cancer Trials Group (CCTG) IND211: A randomized trial of pelareorep (Reolysin) in patients with previously treated advanced or metastatic non-small cell lung cancer receiving standard salvage therapy  Academic Article
• Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens  Academic Article
• Canadian Cohort Expanded-Access Program of Nivolumab Plus Ipilimumab in Advanced Melanoma  Academic Article
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline  Academic Article
• Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation  Academic Article
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial  Academic Article
• Carboplatin hypersensitivity presenting as coronary vasospasm - a case report  Academic Article
• Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial  Academic Article
• Cervical Cancer During Pregnancy  Academic Article
• Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial  Academic Article
• Chemosensitization of gemcitabine-resistant human bladder cancer cell line bothin vitroandin vivousing antisense oligonucleotide targeting the anti-apoptotic gene, clusterin  Academic Article
• Chemotherapy and endocrine therapy in metastatic disease.  Academic Article
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.  Academic Article
• Chemotherapy for Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive-Histology Non-Hodgkin Lymphoma  Academic Article
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?  Academic Article
• Chemotherapy for colorectal cancer  Academic Article
• Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer  Academic Article
• Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma  Academic Article
• Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.  Academic Article
• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients  Academic Article
• Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System  Academic Article
• Classification of treatment-related mortality in children with cancer: a systematic assessment  Academic Article
• Clinical application of the concept of methotrexate plus 5-FU sequence-dependent "synergy": how good is the evidence?  Academic Article
• Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial  Academic Article
• Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.  Academic Article
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer  Academic Article
• Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer  Academic Article
• Clinical trial update: National Cancer Institute of Canada  Academic Article
• Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study  Academic Article
• Cohort Study of Somatostatin-Based Radiopeptide Therapy With [⁹⁰Y-DOTA]-TOC Versus [⁹⁰Y-DOTA]-TOC Plus [¹⁷⁷Lu-DOTA]-TOC in Neuroendocrine Cancers  Academic Article
• Colorectal Cancer in Young Adults  Academic Article
• Colorectal cancer in adolescents and young adults: Defining a growing threat  Academic Article
• Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.  Academic Article
• Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer  Academic Article
• Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.  Academic Article
• Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trial  Academic Article
• Combined Modality Therapy of Esophageal Cancer  Academic Article
• Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells  Academic Article
• Combined Treatment of a Murine Breast Cancer Model with Type 5 Adenovirus Vectors Expressing Murine Angiostatin and IL-12: A Role for Combined Anti-Angiogenesis and Immunotherapy  Academic Article
• Combined chemotherapy and radiation therapy for non-small-cell lung cancer.  Academic Article
• Combined methotrexate–dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia  Academic Article
• Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.  Academic Article
• Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus  Academic Article
• Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.  Academic Article
• Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial  Conference Paper
• Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?  Academic Article
• Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic Regimens  Conference Paper
• Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation  Academic Article
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials  Academic Article
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer:  Academic Article
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer–a Meta-analysis  Academic Article
• Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis  Academic Article
• Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials  Academic Article
• Conventional and Complementary Therapies: A Tale of Two Research Standards?  Academic Article
• Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada  Academic Article
• Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma  Academic Article
• Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma  Academic Article
• Creatinine as a Measure of Lean Body Mass During Treatment of Acute Lymphoblastic Leukemia in Childhood  Academic Article
• Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons  Academic Article
• Current approaches to the treatment of advanced-stage Hodgkin's disease.  Academic Article
• Current approaches to the treatment of advanced-stage non-Hodgkin's lymphoma.  Academic Article
• Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer  Academic Article
• Current status of adjuvant endocrine therapy for resectable breast cancer.  Academic Article
• Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial  Academic Article
• Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial  Academic Article
• Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.  Academic Article
• Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer  Academic Article
• Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms  Academic Article
• Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study  Academic Article
• Decision Framework for Chemotherapeutic Interventions for Metastatic Non-Small-Cell Lung Cancer  Academic Article
• Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature  Academic Article
• Detection of a clone-specific GATA1 mutation to monitor treatment response and involvement of a monozygotic twin in myeloid leukemia of Down syndrome  Academic Article
• Disabling Encephalopathy During 5-Fluorouracil and Levamisole Adjuvant Therapy for Resected Colorectal Cancer: A Report of Two Cases  Academic Article
• Disparities in treatment patterns and outcomes among younger and older adults with newly diagnosed multiple myeloma: A population-based study  Academic Article
• Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study  Academic Article
• Does the Addition of Biologic Agents to Chemotherapy in Patients with Unresectable Colorectal Cancer Metastases Result in a Higher Proportion of Patients Undergoing Resection? A Systematic Review and Meta-analysis  Academic Article
• Donor leukocyte infusions for multiple myeloma  Academic Article
• Dose intensity and lymphoma.  Academic Article
• Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer  Academic Article
• Drug-Induced Stomatocytosis and Anemia During Consolidation Chemotherapy of Childhood Acute Leukemia  Academic Article
• Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones  Academic Article
• Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events  Academic Article
• Duration of Androgen Suppression Before Radiotherapy for Localized Prostate Cancer: Radiation Therapy Oncology Group Randomized Clinical Trial 9910  Academic Article
• Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)  Academic Article
• Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial  Academic Article
• Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer  Academic Article
• Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder  Academic Article
• EBV DNA: a Hodgkin lymphoma biomarker?  Academic Article
• Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report  Academic Article
• Early and late changes in markers of aortic stiffness with breast cancer therapy  Academic Article
• Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture  Academic Article
• Early-stage Hodgkin's disease: current approaches to treatment.  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme  Academic Article
• Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood  Academic Article
• Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer  Academic Article
• Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer  Academic Article
• Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.  Academic Article
• Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^*  Academic Article
• Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study  Academic Article
• Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer  Academic Article
• Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators  Academic Article
• Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia  Academic Article
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Academic Article
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Academic Article
• Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer  Academic Article
• Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001  Academic Article
• Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs  Academic Article
• Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy  Academic Article
• Efficacy of Chinese herbal injections combined with fluoropyrimidine and oxaliplatin-based chemotherapy for advanced colorectal cancer  Academic Article
• Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17  Conference Paper
• Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials  Academic Article
• Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial  Academic Article
• Eight Cycles of ABVD Versus Four Cycles of BEACOPP_escalated Plus Four Cycles of BEACOPP_baseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial  Academic Article
• Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference  Academic Article
• Endocrine disorders following treatment of childhood brain tumours  Academic Article
• Endodermal Sinus Tumor in Pregnancy  Academic Article
• Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer  Academic Article
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline  Academic Article
• Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group.  Academic Article
• Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma  Academic Article
• Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial  Academic Article
• Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination  Academic Article
• Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis  Academic Article
• Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma  Academic Article
• Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy  Academic Article
• Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen‐receptor–targeted therapy for metastatic castration‐resistant prostate cancer  Academic Article
• Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size  Academic Article
• Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report  Academic Article
• Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer  Academic Article
• Expression of p27 in Residual Rectal Cancer after Preoperative Chemoradiation Predicts Long-term Outcome  Academic Article
• External validation of the FIRST trial’s simplified frailty score in a population-based cohort  Academic Article
• FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy  Academic Article
• Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study  Academic Article
• Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma  Academic Article
• Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas  Academic Article
• Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma  Conference Paper
• Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study  Academic Article
• Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial  Academic Article
• First line therapy with paclitaxel (Taxol®) and pegylated liposomal doxorubicin (Caelyx®) in patients with metastatic breast cancer: a multicentre phase II study  Academic Article
• First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review  Academic Article
• First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients  Academic Article
• Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors  Academic Article
• Forearm pyomyositis in a breast cancer patient on chemotherapy  Academic Article
• Foreign Body Reaction Mimicking Breast Carcinoma in Patient with Stage IV Ovarian Cancer  Academic Article
• Future Directions for Research on Silybum marianum for Cancer Patients  Academic Article
• GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy  Academic Article
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer  Academic Article
• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter  Academic Article
• Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience  Academic Article
• Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma  Academic Article
• Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12  Academic Article
• Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer  Academic Article
• Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy  Academic Article
• Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients  Academic Article
• HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data  Academic Article
• HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome  Academic Article
• Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol  Academic Article
• Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada  Academic Article
• Health-Related Quality of Life in Men With Metastatic Prostate Cancer Treated With Prednisone Alone or Mitoxantrone and Prednisone  Academic Article
• Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2⁻advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy  Academic Article
• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial  Academic Article
• Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment  Academic Article
• Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials  Academic Article
• Hemophagocytic Lymphohistiocytosis Onset During Induction Therapy for Precursor B-cell Acute Lymphoblastic Leukemia  Academic Article
• Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness  Academic Article
• High Dose Therapy with Stem Cell Support for Breast Cancer: The Jury Is Still Out  Academic Article
• Hospital and home chemotherapy for children with leukemia: A randomized cross-over study  Academic Article
• Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: Possible mechanisms  Academic Article
• Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study  Academic Article
• Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials  Academic Article
• Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence  Academic Article
• Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001  Academic Article
• Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer  Academic Article
• Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer  Academic Article
• Immediate Versus Delayed Access of Implantable Venous Access Devices: Does the Timing of Access Make a Difference to the Frequency of Complications?  Academic Article
• Immune Checkpoint Inhibitors for Patients With Advanced Non–Small-Cell Lung Cancer: A Systematic Review  Academic Article
• Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells  Academic Article
• Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial  Academic Article
• Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients  Academic Article
• Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia  Academic Article
• Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada  Academic Article
• Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01  Academic Article
• Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent  Academic Article
• Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5  Academic Article
• Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer  Academic Article
• Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Induction failure in acute lymphoblastic leukemia of childhood  Academic Article
• Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception  Academic Article
• Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect  Academic Article
• Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin  Academic Article
• Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study  Academic Article
• Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.  Academic Article
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Academic Article
• Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies  Academic Article
• Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies  Academic Article
• Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia [letter]  Academic Article
• Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol  Academic Article
• Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?  Academic Article
• KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation  Academic Article
• Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.  Academic Article
• Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability  Academic Article
• Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31  Academic Article
• Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial  Academic Article
• Lenalidomide Plus Melphalan Without Prednisone for Previously Untreated Older Patients With Multiple Myeloma: A Phase II Trial  Academic Article
• Less intensive antileukemic therapies (monotherapy and/or combination) for older adults with acute myeloid leukemia who are not candidates for intensive antileukemic therapy: A systematic review and meta-analysis  Academic Article
• Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis  Academic Article
• Limited-Stage Hodgkin Lymphoma: Managing Uncertainty  Academic Article
• Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases  Academic Article
• Locally advanced breast cancer in octogenarian women  Academic Article
• Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy  Academic Article
• Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia  Academic Article
• Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia  Academic Article
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)  Academic Article
• Long-term survival following extra-neural metastasis from a pineoblastoma.  Academic Article
• Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)  Academic Article
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conference Paper
• Lung cancer chemotherapy agents increase procoagulant activity via protein disulfide isomerase-dependent tissue factor decryption  Academic Article
• Lung cancer.  Academic Article
• Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis  Academic Article
• Maintenance therapy in transplant ineligible adults with newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis  Academic Article
• Malignant Pleural Mesothelioma  Academic Article
• Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols  Academic Article
• Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.  Academic Article
• Management of advanced or recurrent cervical cancer: chemotherapy and beyond  Academic Article
• Management of unresected stage III non-small cell lung cancer: a systematic review.  Academic Article
• Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial  Academic Article
• Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.  Academic Article
• Melena: a rare presentation of childhood Burkitt's lymphoma  Academic Article
• Metastatic Merkel cell tumor to the prostate and bladder  Academic Article
• Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer  Academic Article
• Metformin—A Thought-provoking Addition to Anticancer Therapies—Reply  Academic Article
• Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology  Academic Article
• Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.  Academic Article
• Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia  Academic Article
• Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.  Academic Article
• More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?  Academic Article
• Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set  Academic Article
• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer  Academic Article
• NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer  Academic Article
• Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases  Academic Article
• Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients  Academic Article
• Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Academic Article
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America  Academic Article
• Neonatal Hepatoblastoma: Two Cases Posing a Diagnostic Dilemma, with a Review of the Literature  Academic Article
• Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma  Academic Article
• Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01  Academic Article
• Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome  Academic Article
• Neutropenia as a Potential Pharmacodynamic Marker for Docetaxel-Based Chemotherapy in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• New therapeutic strategies to treat human cancers expressing mutant p53 proteins  Academic Article
• Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Academic Article
• Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study  Academic Article
• Nomograms to Predict Serious Adverse Events in Phase II Clinical Trials of Molecularly Targeted Agents  Academic Article
• OSTEOSARCOMA AND PULMONARY METASTASES: 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION  Academic Article
• Obstructive jaundice caused by neuroblastoma managed with temporary cholecystostomy tube  Academic Article
• Octreotide LAR and tamoxifen versus tamoxifen in phase III randomize early breast cancer trials: NCIC CTG MA.14 and NSABP B-29  Academic Article
• Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer  Conference Paper
• Oligodendroglioma  Academic Article
• Ondansetron Compared with Dexamethasone and Metoclopramide as Antiemetics in the Chemotherapy of Breast Cancer with Cyclophosphamide, Methotrexate, and Fluorouracil  Academic Article
• Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy  Academic Article
• Opinions in pediatric and adolescent gynecology  Academic Article
• Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)  Academic Article
• Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration  Academic Article
• Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline  Academic Article
• Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate  Academic Article
• Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001  Academic Article
• Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013  Academic Article
• Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site  Academic Article
• Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy  Academic Article
• Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704  Academic Article
• Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database  Academic Article
• Ovarian ablation as adjuvant therapy for early-stage breast cancer  Academic Article
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study  Academic Article
• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.  Academic Article
• Overstated Conclusions of a Pooled Analysis of Bevacizumab in Colon Cancer  Academic Article
• PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy  Academic Article
• PML/RARα APL with undifferentiated morphology and stem cell immunophenotype  Academic Article
• Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial  Academic Article
• Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4  Academic Article
• Paraspinal Synovial Sarcoma as an Unusual Postradiation Complication in Pediatric Abdominal Neuroblastoma  Academic Article
• Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx  Academic Article
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Academic Article
• Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma  Academic Article
• Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial  Conference Paper
• Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial  Academic Article
• Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial  Conference Paper
• Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome  Academic Article
• Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial  Academic Article
• Pharmacoeconomics of Systemic Therapies for Lung Cancer  Academic Article
• Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity  Academic Article
• Pharmacokinetics, Safety, and Efficacy of Trastuzumab Administered Every Three Weeks in Combination With Paclitaxel  Academic Article
• Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women  Academic Article
• Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease  Academic Article
• Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations  Academic Article
• Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer  Academic Article
• Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma  Academic Article
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors  Academic Article
• Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients  Academic Article
• Phase I Study of Combination Topotecan and Carboplatin in Pediatric Solid Tumors  Academic Article
• Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas  Academic Article
• Phase I Targeted Combination Trial of Sorafenib and Erlotinib in Patients with Advanced Solid Tumors  Academic Article
• Phase I Trial of Granulocyte-Macrophage Colony-Stimulating Factor With High-Dose Cisplatin and Etoposide for Treatment of Small-Cell Lung Cancer: A Study of the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer  Academic Article
• Phase I and Pharmacokinetic Study of Daily Oral AZD2171, an Inhibitor of Vascular Endothelial Growth Factor Tyrosine Kinases, in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non–Small-Cell Lung Cancer: The National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer  Academic Article
• Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)  Academic Article
• Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218  Academic Article
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study  Academic Article
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors  Academic Article
• Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer  Academic Article
• Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study  Conference Paper
• Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response  Academic Article
• Phase II Study of Sequential Topotecan and Etoposide in Patients with Intermediate Grade Non-Hodgkin's Lymphoma: A National Cancer Institute of Canada Clinical Trials Group Study  Academic Article
• Phase II Trial of 13-cis-Retinoic Acid Plus Interferon   in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group  Academic Article
• Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer  Academic Article
• Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response  Academic Article
• Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy  Academic Article
• Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma  Academic Article
• Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.  Academic Article
• Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer  Academic Article
• Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma  Academic Article
• Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.  Academic Article
• Phase III Comparative Study of Vinorelbine Combined With Doxorubicin Versus Doxorubicin Alone in Disseminated Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8  Academic Article
• Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19  Academic Article
• Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma  Academic Article
• Phase‐specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group‐based treatment for childhood acute lymphoblastic leukemia: A population‐based study  Academic Article
• Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis  Academic Article
• Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain  Academic Article
• Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study  Academic Article
• Platinum-based chemotherapy in triple-negative advanced breast cancer  Academic Article
• Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy  Academic Article
• Polychemotherapy for early breast cancer: an overview of the randomised trials  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy  Academic Article
• Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer  Academic Article
• Pre-operative bevacizumab, capecitabine, oxaliplatin and radiation among patients with locally advanced or low rectal cancer: A phase II trial  Academic Article
• Predicting Anthracycline Benefit: TOP2A and CEP17—Not Only but Also  Academic Article
• Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements  Academic Article
• Predictors of bony morbidity in children with acute lymphoblastic leukemia  Academic Article
• Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline  Academic Article
• Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer  Academic Article
• Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma  Academic Article
• Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer  Academic Article
• Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial  Academic Article
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial  Academic Article
• Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer  Academic Article
• Prognostic factors in patients with small-cell carcinoma of the lung.  Academic Article
• Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy  Academic Article
• Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: A prospective analysis of 437 cases and its application for designing induction chemotherapy trials  Academic Article
• Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy  Academic Article
• Prophylactic Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Decrease Febrile Neutropenia After Chemotherapy in Children With Cancer: A Meta-Analysis of Randomized Controlled Trials  Academic Article
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario  Academic Article
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.  Academic Article
• Protocol-based treatment for children with cancer in low income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part II  Academic Article
• Pulmonary lymphangiomyomatosis complicating pregnancy. A case report.  Academic Article
• Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report  Academic Article
• Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia  Academic Article
• Quality of Life Analyses in a Clinical Trial of DPPE (tesmilifene) Plus Doxorubicin Versus Doxorubicin in Patients with Advanced or Metastatic Breast Cancer: NCIC CTG Trial MA.19  Academic Article
• R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial  Academic Article
• Radiation in early-stage Hodgkin lymphoma.  Academic Article
• Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer  Academic Article
• Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.  Academic Article
• Radiotherapy to control CNS lymphomatoid granulomatosis: A case report and review of the literature  Academic Article
• Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29  Academic Article
• Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study  Academic Article
• Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group  Academic Article
• Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12  Academic Article
• Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer  Conference Paper
• Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer  Conference Paper
• Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c  Academic Article
• Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen  Academic Article
• Randomized Phase III Study of Matrix Metalloproteinase Inhibitor BMS-275291 in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18  Academic Article
• Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer  Conference Paper
• Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5  Academic Article
• Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16  Academic Article
• Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17  Academic Article
• Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14  Academic Article
• Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.  Academic Article
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer  Academic Article
• Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy  Academic Article
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.  Academic Article
• Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study  Academic Article
• Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma  Academic Article
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Real-World Use of Trifluridine/Tipiracil for Patients with Metastatic Colorectal Cancer in Canada  Academic Article
• Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database  Academic Article
• Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative  Academic Article
• Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration‐resistant prostate cancer treated with custirsen  Academic Article
• Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14  Academic Article
• Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia  Academic Article
• Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia  Academic Article
• Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived  Academic Article
• Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial  Academic Article
• Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial  Academic Article
• Results of a Multicenter Randomized Phase II Trial of Thalidomide and Prednisone Maintenance Therapy for Multiple Myeloma after Autologous Stem Cell Transplant  Academic Article
• Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Risk of Menopause During the First Year After Breast Cancer Diagnosis  Academic Article
• Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma  Academic Article
• Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy  Academic Article
• Role of Gonadotropin-Releasing Hormone Analog in the Management of Male Metastatic Breast Cancer Is Uncertain  Academic Article
• Safety Analysis of Four Randomized Controlled Studies of Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma  Academic Article
• Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2  Academic Article
• Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression  Academic Article
• Safety of bevacizumab in metastatic breast cancer patients undergoing surgery  Academic Article
• Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study  Academic Article
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12  Academic Article
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas  Academic Article
• Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.  Academic Article
• Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline  Academic Article
• Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review  Academic Article
• Selection of adjuvant chemotherapy for treatment of node-positive breast cancer  Academic Article
• Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219  Academic Article
• Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database  Academic Article
• Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer  Academic Article
• Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy  Academic Article
• Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?  Academic Article
• Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis  Academic Article
• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy  Academic Article
• Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811  Conference Paper
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.  Academic Article
• Skeletal Morbidity in Childhood Acute Lymphoblastic Leukemia  Academic Article
• Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium  Academic Article
• Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature  Academic Article
• Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial  Academic Article
• Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials  Academic Article
• Successful treatment of neonatal trilateral retinoblastoma  Academic Article
• Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer  Academic Article
• Superiority of Granisetron to Dexamethasone Plus Prochlorperazine in the Prevention of Chemotherapy-Induced Emesis  Academic Article
• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer  Academic Article
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants  Academic Article
• Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database  Academic Article
• Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa  Academic Article
• Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy  Academic Article
• Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate—5-fluorouracil chemotherapy in head and neck cancer  Academic Article
• Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study  Academic Article
• Systematic Chemotherapy for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma: A Systematic Review  Academic Article
• Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?  Academic Article
• Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial  Academic Article
• Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma  Academic Article
• Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review  Academic Article
• Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review  Academic Article
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy  Academic Article
• TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients  Academic Article
• Tailored targeted therapy for all: a realistic and worthwhile objective against  Academic Article
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Academic Article
• Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.  Academic Article
• Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?  Academic Article
• Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline  Academic Article
• Teclistamab in Relapsed or Refractory Multiple Myeloma  Academic Article
• Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)  Academic Article
• Thalidomide-prednisone maintenance following autologous stem cell transplant for Multiple Myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10  Academic Article
• The Bipartisan Colon  Academic Article
• The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group  Academic Article
• The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast Cancer  Academic Article
• The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma  Academic Article
• The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis  Academic Article
• The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review  Academic Article
• The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative  Academic Article
• The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer  Academic Article
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Academic Article
• The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer  Academic Article
• The chemotherapy of granulosa cell tumors of the ovary: Experience of the wisconsin clinical cancer center  Academic Article
• The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia  Academic Article
• The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation  Academic Article
• The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma  Academic Article
• The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells  Academic Article
• The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy  Academic Article
• The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation  Conference Paper
• The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.  Academic Article
• The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study  Academic Article
• The treatment of patients with acute nonlymphocytic leukemia in remission.  Academic Article
• The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure  Academic Article
• The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.  Academic Article
• The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.  Academic Article
• Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline  Academic Article
• Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease  Academic Article
• Thrombosis in Children with Acute Lymphoblastic Leukemia Treated at a Tertiary Care Center in Lebanon: Revisiting the Role of Predictive Models  Academic Article
• Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor  Academic Article
• Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.  Academic Article
• Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer  Academic Article
• Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial  Academic Article
• Toxic megacolon associated with anticancer chemotherapy.  Academic Article
• Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials  Academic Article
• Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study  Academic Article
• Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma  Academic Article
• Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study  Academic Article
• Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.  Academic Article
• Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.  Academic Article
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conference Paper
• Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup study  Academic Article
• Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma  Academic Article
• Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24  Academic Article
• Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor  Academic Article
• UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium  Academic Article
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Academic Article
• Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma  Academic Article
• Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy  Academic Article
• Use and Misuse of Waterfall Plots  Academic Article
• Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.  Academic Article
• Use of human dura in pediatric chest wall reconstruction after tumor resection  Conference Paper
• Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.  Academic Article
• Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients  Academic Article
• VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma  Academic Article
• Vaginal Yolk Sac Tumor in an Infant  Academic Article
• Validated or Not Validated? That Is the Question  Academic Article
• Validation of an algorithmic nutritional approach in children undergoing chemotherapy for cancer  Academic Article
• Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421  Academic Article
• Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study  Academic Article
• Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia  Academic Article
• Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.  Academic Article
• Weight gain in breast cancer survivors: prevalence, pattern and health consequences  Academic Article
• Women's perceptions of home-based exercise performed during adjuvant chemotherapy for breast cancer  Academic Article
• [A multicenter, large-sample, randomized clinical trial on improving the median survival time of advanced non-small cell lung cancer by combination of Ginseng Rg3 and chemotherapy].  Academic Article
• [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].  Academic Article